Core Scientific, Inc. CORZ Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 11.9%-11.8pp | 23.7%-0.9pp | 24.6%— | —— | |
| Operating margin | -78.4%-50.6pp | -27.8%-29.6pp | 1.8%+331pp | -329.5%-354pp | |
| EBITDA margin | -56.8%-51.1pp | -5.7%-26.5pp | 20.9%+315pp | -294.3%-318pp | |
| Free cash flow margin | -141.3%-131pp | -10.2%-19.9pp | 9.7%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.2×-0.3× | 0.5×-0.2× | 0.7×+0.3× | 0.4×-0.1× | |
| Liquidity | |||||
| Current ratio | 1.1×-5.6× | 6.7×+6.5× | 0.2×-0.3× | 0.5×-1.9× | |
| Quick ratio | 1.1×-5.6× | 6.7×+6.5× | 0.2×-0.3× | 0.5×-1.9× | |
| Cash ratio | 0.4×-5.8× | 6.2×+6.1× | 0.1×-0.1× | 0.3×-0.1× | |
| Leverage | |||||
| Debt-to-assets | 0.5×-0.3× | 0.8×-0.3× | 1.1×+1.1× | 0×-0.3× | |
| Per Share | |||||
| Book value per share | -$3.03+17.9% | -$3.69-135% | -$1.57-30.8% | -$1.20-121% | |
| Valuation | |||||
| Market capitalization | $4.51B+15.1% | $3.92B— | —— | —— | |
| Enterprise value | $5.37B+25.6% | $4.27B— | —— | —— | |
| Price / sales | 14.2×+6.5× | 7.7×— | —— | —— | |
| EV / sales | 16.8×+8.5× | 8.4×— | —— | —— | |
| Free cash flow yield | -10%-8.7pp | -1.3%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Core Scientific, Inc.'s profit margins?
- Core Scientific, Inc. (CORZ) runs a 16.9% gross margin and a -144.7% operating margin, with a -238.9% net margin.
- Where do Core Scientific, Inc.'s ratios come from?
- Every ratio is computed from Core Scientific, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
